GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Cyclically Adjusted PB Ratio

Medicure (TSXV:MPH) Cyclically Adjusted PB Ratio : 0.45 (As of Jun. 07, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Medicure Cyclically Adjusted PB Ratio?

As of today (2024-06-07), Medicure's current share price is C$1.08. Medicure's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was C$2.42. Medicure's Cyclically Adjusted PB Ratio for today is 0.45.

The historical rank and industry rank for Medicure's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSXV:MPH' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.13   Med: 0.98   Max: 216.67
Current: 0.46

During the past years, Medicure's highest Cyclically Adjusted PB Ratio was 216.67. The lowest was 0.13. And the median was 0.98.

TSXV:MPH's Cyclically Adjusted PB Ratio is ranked better than
87.52% of 737 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs TSXV:MPH: 0.46

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medicure's adjusted book value per share data for the three months ended in Mar. 2024 was C$1.965. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is C$2.42 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medicure Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Medicure's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure Cyclically Adjusted PB Ratio Chart

Medicure Annual Data
Trend May14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.36 0.95 0.52 0.48 0.60

Medicure Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.51 0.71 0.60 0.47

Competitive Comparison of Medicure's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Medicure's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicure's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicure's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medicure's Cyclically Adjusted PB Ratio falls into.



Medicure Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Medicure's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.08/2.42
=0.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicure's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Medicure's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.965/126.2576*126.2576
=1.965

Current CPI (Mar. 2024) = 126.2576.

Medicure Quarterly Data

Book Value per Share CPI Adj_Book
201311 -0.432 97.182 -0.561
201402 -0.418 98.051 -0.538
201405 -0.482 99.394 -0.612
201408 -0.354 99.315 -0.450
201503 -0.202 99.789 -0.256
201506 0.124 100.500 0.156
201509 0.136 100.421 0.171
201512 0.309 99.947 0.390
201603 0.352 101.054 0.440
201606 0.456 102.002 0.564
201609 0.669 101.765 0.830
201612 2.330 101.449 2.900
201703 1.981 102.634 2.437
201706 2.125 103.029 2.604
201709 1.326 103.345 1.620
201712 5.114 103.345 6.248
201803 5.279 105.004 6.348
201806 5.413 105.557 6.475
201809 5.333 105.636 6.374
201812 5.377 105.399 6.441
201903 5.151 106.979 6.079
201906 5.010 107.690 5.874
201909 4.978 107.611 5.841
201912 2.494 107.769 2.922
202003 2.503 107.927 2.928
202006 2.415 108.401 2.813
202009 2.297 108.164 2.681
202012 1.868 108.559 2.173
202103 1.748 110.298 2.001
202106 1.680 111.720 1.899
202109 1.663 112.905 1.860
202112 1.796 113.774 1.993
202203 1.828 117.646 1.962
202206 1.813 120.806 1.895
202209 2.045 120.648 2.140
202212 2.049 120.964 2.139
202303 2.081 122.702 2.141
202309 2.095 125.230 2.112
202312 1.906 125.072 1.924
202403 1.965 126.258 1.965

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medicure  (TSXV:MPH) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Medicure Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Medicure's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicure (TSXV:MPH) Business Description

Traded in Other Exchanges
Address
2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6
Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.
Executives
Albert David Friesen Director, Senior Officer

Medicure (TSXV:MPH) Headlines

No Headlines